Concord Medical Services Holdings Limited, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
| Revenue (TTM) | $365.76M |
| Gross Profit (TTM) | $-41.85M |
| EBITDA | $-356.79M |
| Operating Margin | -72.10% |
| Return on Equity | -29.00% |
| Return on Assets | -4.48% |
| Revenue/Share (TTM) | $83.73 |
| Book Value | $-74.75 |
| Price-to-Book | 3.00 |
| Price-to-Sales (TTM) | 0.04 |
| EV/Revenue | 10.29 |
| EV/EBITDA | -0.96 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -8.30% |
| Shares Outstanding | $2.82M |
| Float | $42.20M |
| % Insiders | 18.00% |
| % Institutions | 0.04% |
Volatility is currently contracting